| Literature DB >> 24357832 |
Sang Mee Hwang1, Cha-Ja See2, Jungeun Choi3, Seon Young Kim2, Qute Choi2, Jung Ah Kim2, Jiseok Kwon4, Si Nae Park4, Kyongok Im4, Il-Hoan Oh5, Dong Soon Lee6.
Abstract
The cytogenetic analysis of mesenchymal stromal cells (MSCs) is essential for verifying the safety and stability of MSCs. An in situ technique, which uses cells grown on coverslips for karyotyping and minimizes cell manipulation, is the standard protocol for the chromosome analysis of amniotic fluids. Therefore, we applied the in situ karyotyping technique in MSCs and compared the quality of metaphases and karyotyping results with classical G-banding and chromosomal abnormalities with fluorescence in situ hybridization (FISH). Human adipose- and umbilical cord-derived MSC cell lines (American Type Culture Collection PCS-500-011, PCS-500-010) were used for evaluation. The quality of metaphases was assessed by analyzing the chromosome numbers in each metaphase, the overlaps of chromosomes and the mean length of chromosome 1. FISH was performed in the interphase nuclei of MSCs for 6q, 7q and 17q abnormalities and for the enumeration of chromosomes via oligo-FISH in adipose-derived MSCs. The number of chromosomes in each metaphase was more variable in classical G-banding. The overlap of chromosomes and the mean length of chromosome 1 as observed via in situ karyotyping were comparable to those of classical G-banding (P=0.218 and 0.674, respectively). Classical G-banding and in situ karyotyping by two personnel showed normal karyotypes for both cell lines in five passages. No numerical or structural chromosomal abnormalities were found by the interphase-FISH. In situ karyotyping showed equivalent karyotype results, and the quality of the metaphases was not inferior to classical G-banding. Thus, in situ karyotyping with minimized cell manipulation and the use of less cells would be useful for karyotyping MSCs.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24357832 PMCID: PMC3880460 DOI: 10.1038/emm.2013.133
Source DB: PubMed Journal: Exp Mol Med ISSN: 1226-3613 Impact factor: 8.718
Figure 1Distribution of the number of chromosomes in each metaphase using classical G-banding and in situ karyotyping. (1) Hypotonic solution with 0.075 M KCl and (2) hypotonic solution with 0.054 M KCl.
Figure 2Chromosome overlaps in metaphases. Metaphases with (a) no overlap and (b) chromosome overlaps.
The karyotyping results of mesenchymal stromal cell lines and other adherent cell lines via classical G-banding and in situ karyotyping
| A-MSC-1 | 46,XY[20] | 46,XY[20] | 46,XY[20] | 46,XY[20] |
| A-MSC-2 | 46,XY[20] | 46,XY[20] | 46,XY[20] | 46,XY[20] |
| A-MSC-3 | 46,XY[20] | 46,XY[20] | 46,XY[20] | 46,XY[20] |
| A-MSC-4 | 46,XY[20] | 46,XY[20] | 46,XY[20] | 46,XY[20] |
| A-MSC-5 | 46,XY[11] | 46,XY[14] | 46,XY[20] | 46,XY[20] |
| C-MSC-1 | 46,XY[20] | 46,XY[15] | 46,XY[20] | 46,XY[20] |
| C-MSC-2 | 46,XY[20] | 46,XY[20] | 46,XY[20] | 46,XY[20] |
| C-MSC-3 | 46,XY[20] | 46,XY[20] | 46,XY[20] | 46,XY[20] |
| C-MSC-4 | 46,XY[20] | 46,XY[20] | 46,XY[20] | 46,XY[20] |
| C-MSC-5 | 46,XY[20] | 46,XY[20] | 46,XY[15] | 46,XY[11] |
| DLD-1 | 46,XY,dup(2)(p13p22)[20] | 46,XY,dup(2)(p13p22)[20] | 46,XY,dup(2)(p13p22)[20] | 46,XY,dup(2)(p13p22)[20] |
| HCT-116 | 45,X,−Y,der(10)t(10;?) (q26.1;?),der(16)t(16;?)(p13.3;?),der(18)t(18;?)(p11.32;?)[18]/46,iden,+Y[2] | 45,X,−Y,der(10)t(10;?) (q26.1;?),der(16)t(16;?)(p13.3;?),der(18)t(18;?)(p11.32;?)[17]/45,idem,inv(1)(p36.1q32.1)[3] | 45,X,−Y,der(10)t(10;?) (q26.1;?),der(16)t(16;?)(p13.3;?),der(18)t(18;?)(p11.32;?)[15]/45,idem,dup(5)(p13p15.1)[3]/46,idem,+Y[2] | 45,X,−Y,der(10)t(10;?) (q26.1;?),der(16)t(16;?)(p13.3;?),der(18)t(18;?)(p11.32;?)[20] |
Abbreviation: MSC, mesenchymal stromal cell.
The results of FISH for enumerating chromosomes in adipose-derived MSCs
| A-MSC-1 | 100.0 | 98.0 | 98.0 | 99.0 | 99.0 | 98.0 | 98.0 | 98.0 | 98.0 | 99.0 |
| A-MSC-5 | 100.0 | 98.0 | 96.0 | 100.0 | 99.0 | 98.0 | 98.0 | 98.0 | 98.0 | 100.0 |
| Chr. 11 | Chr. 12 | Chr. 13/21 | Chr. 14/22 | Chr. 15 | Chr. 16 | Chr. 17 | Chr. 18 | Chr. 19 | Chr. 20 | |
| A-MSC-1 | 98.0 | 96.0 | 98.0 | 96.0 | 99.0 | 98.0 | 97.0 | 96.0 | 100.0 | 98.0 |
| A-MSC-5 | 97.0 | 97.0 | 94.0 | 99.0 | 99.0 | 98.0 | 99.0 | 98.0 | 100.0 | 97.0 |
Abbreviations: FISH, fluorescence in situ hybridization; MSC, mesenchymal stromal cell.
Results ⩾94% are considered to be within a normal limit.
Interphase FISH results for 6q, 7q and 17q abnormalities in MSC cell lines
| A-MSC-1 | 97.5 | 98.5 | 97.0 |
| A-MSC-5 | 97.5 | 99.0 | 99.5 |
| C-MSC-1 | 98.5 | 98.0 | 98.0 |
| C-MSC-5 | 99.0 | 98.5 | 99.0 |
Abbreviations: FISH, fluorescence in situ hybridization; MSC, mesenchymal stromal cell.
Results ⩾94% are considered to be within a normal limit.